Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium

BACKGROUND: In Belgium, bladder cancer is the fifth most common cancer in males (5.2%) and the sixth most frequent cause of death from cancer in males (3.8%). Previous epidemiological studies have consistently reported that selenium concentrations were inversely associated with the risk of bladder c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Goossens, Maria E, Buntinx, Frank, Joniau, Steven, Ackaert, Koen, Ameye, Filip, Billiet, Ignace, Braeckman, Johan, Breugelmans, Alex, Darras, Jochen, Dilen, Kurt, Goeman, Lieven, Kellen, Eliane, Tombal, Bertrand, Van Bruwaene, Siska, Van Cleyenbreuge, Ben, Van der Aa, Frank, Vekemans, Kris, Van Poppel, Hendrik, Zeegers, Maurice P
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3352119/
https://ncbi.nlm.nih.gov/pubmed/22436453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-12-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki